National Bank of Canada FI Purchases 320,924 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

National Bank of Canada FI increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 262.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 443,248 shares of the company's stock after buying an additional 320,924 shares during the quarter. National Bank of Canada FI owned 0.10% of GE HealthCare Technologies worth $34,661,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. Vanguard Group Inc. grew its position in GE HealthCare Technologies by 4.3% during the 4th quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock worth $4,107,378,000 after acquiring an additional 2,155,429 shares during the last quarter. State Street Corp grew its holdings in shares of GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after purchasing an additional 1,347,114 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock valued at $1,026,898,000 after buying an additional 733,819 shares during the last quarter. Norges Bank acquired a new position in GE HealthCare Technologies during the 4th quarter worth about $488,531,000. Finally, Van ECK Associates Corp lifted its position in GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock worth $378,520,000 after buying an additional 2,506,417 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on GEHC shares. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $97.73.

GE HealthCare Technologies Stock Down 1.1 %

GEHC stock traded down $0.64 during trading hours on Monday, reaching $59.87. 3,634,776 shares of the stock were exchanged, compared to its average volume of 3,026,917. The company has a market cap of $27.38 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 3.19 and a beta of 1.14. The firm's 50-day moving average is $85.41 and its 200-day moving average is $85.40. GE HealthCare Technologies Inc. has a 12 month low of $58.04 and a 12 month high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.23%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.